Westin L, Carlsson R, Erhardt L, Cantor-Graae E, McNeil T
Department of Cardiology, University Hospital, Malmö, Sweden.
Scand Cardiovasc J. 1999;33(3):160-5. doi: 10.1080/14017439950141795.
A study was conducted in Sweden in 1989-1992 to evaluate differences in quality of life (QL) in consecutive male and female patients after acute myocardial infarction (AMI), coronary artery by-pass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA). Somatic and psychological dimensions of QL were assessed by self-administered questionnaire in patients one month (n = 376) and one year (n = 349) after the cardiac event. Normal controls (n = 88) were used for comparison. Differences between gender groups, as well as between study patients and controls in somatic and psychological dimensions of QL were studied. Patients were shown to experience poorer QL when compared with demographically similar controls, especially at the one-month assessment. Female patients had poorer QL after one month (in general health, feeling of arrythmia, anxiety, depression, self-esteem, experience of sex life) and after one year (general health, anxiety, depression) compared with male patients. In all dimensions of QL a proportion of patients (19-45%) experienced a decrease in QL from the one-month to the one-year assessment occasion. Healthcare workers concerned with secondary prevention must be aware that QL differs between male and female patients in several dimensions after a cardiac event. These findings should be taken into account in the clinical management of patients, particularly for female patients who may need special attention.
1989年至1992年在瑞典进行了一项研究,以评估急性心肌梗死(AMI)、冠状动脉旁路移植术(CABG)和经皮腔内冠状动脉成形术(PTCA)后连续的男性和女性患者的生活质量(QL)差异。在心脏事件发生后1个月(n = 376)和1年(n = 349)的患者中,通过自我管理问卷评估QL的躯体和心理维度。使用正常对照组(n = 88)进行比较。研究了性别组之间以及研究患者与对照组在QL躯体和心理维度上的差异。与人口统计学上相似的对照组相比,患者的QL较差,尤其是在1个月评估时。与男性患者相比,女性患者在1个月后(总体健康、心律失常感觉、焦虑、抑郁、自尊、性生活体验)和1年后(总体健康、焦虑、抑郁)的QL较差。在QL的所有维度中,一部分患者(19 - 45%)从1个月评估到1年评估时QL有所下降。参与二级预防的医护人员必须意识到,心脏事件后男性和女性患者在几个维度上的QL存在差异。在患者的临床管理中应考虑这些发现,特别是对于可能需要特别关注的女性患者。